Supplemental material
Journal of Medical Economics
Volume 24, 2021 - Issue 1
Genetic Disease
Economic burden of congenital athymia in the United States for patients receiving supportive care during the first 3 years of life
, 
, , , , & show all
Julie J. Kim-Changc Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Duke University School of Medicine, Durham, NC, USAhttps://orcid.org/0000-0002-9799-9054
https://orcid.org/0000-0002-9799-9054, Elena Hsiehd Department of Pediatrics, Section of Allergy and Immunology, University of Colorado, Anschutz School of Medicine, Children’s Hospital Colorado, Aurora, CO, USA;e Department of Immunology and Microbiology, University of Colorado, Anschutz School of Medicine, Aurora, CO, USAhttps://orcid.org/0000-0003-3969-6597
https://orcid.org/0000-0003-3969-6597, , Matthew O’Haraf Trinity Life Sciences, Waltham, MA, USAhttps://orcid.org/0000-0003-2131-8563
https://orcid.org/0000-0003-2131-8563, & Megan A. Cooperh Department of Pediatrics, Division of Rheumatology/Immunology, Washington University in St. Louis, St. Louis, MO, USACorrespondence[email protected]
https://orcid.org/0000-0002-5696-172X
https://orcid.org/0000-0002-5696-172X show allRelated Research Data
Economic burden of congenital athymia in the United States for patients receiving supportive care during the first 3 years of life
Source:
Taylor & Francis
Linking provided by
